Retiro De Equipo (Recall) de CARDIOSAVE Hybrid and Rescue Intra-aortic Balloon Pumps (IABP) (Used to inflate and deflate intra-aortic balloons for temporary support of the left ventricle via the principle of counter-pulsation)

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Maquet Australia Pty Ltd.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
  • ID del evento
  • Clase de Riesgo del Evento
    Class I
  • Fecha de inicio del evento
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    Maquet has received reports that, in some cardiosave iabps, the scroll compressor did not meet the specifications for output pressure or vacuum at specific flow rates. when the scroll compressor fails, one of two high priority alarms will appear on the iabp display and patient therapy could be interrupted. the high priority alarms are “autofill failure” and “iab catheter restriction”. if either of the high priority alarms cannot be resolved, the event may be attributable to the scroll compressor failure and therapy to the patient cannot be manually restarted.In this situation and where supported by the iabp to stabilise their haemodynamic status, patients present with critical conditions (particularly those in transit), there is a risk for severe and possible irreversible injury.There are no complaints reported associated with a patient injury or death.
  • Acción
    Maquet is providing work around instructions for users to follow as an interim measure. A software upgrade will be installed as a permanent correction. An updated operator’s manual is being provided which includes additional important information regarding the configuration, alarms in the presence of ESI and self-checks for the compressor. Users are advised the units can continue to be used while the software is being implemented, however it is recommended that if available, they use an alternative unaffected device based on the individual benefit-risk assessment and particularly for patients in transit. If users choose to use an affected CARDIOSAVE IABP it is recommended that an alternative device is available for back-up.


  • Modelo / Serial
    CARDIOSAVE Hybrid and Rescue Intra-aortic Balloon Pumps (IABP) (Used to inflate and deflate intra-aortic balloons for temporary support of the left ventricle via the principle of counter-pulsation)Part Numbers: 0998-00-0800-XX and 0998-UC-0800-XXDistributed between 6 March 2012 to 20 October 2015ARTG Number: 118266
  • Clasificación del producto
  • Manufacturer


  • Empresa matriz del fabricante (2017)
  • Source